Synovium and the Innate Inflammatory Network in Osteoarthritis Progression

被引:157
作者
Liu-Bryan, Ru [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, San Diego, CA 92161 USA
[2] Univ Calif San Diego, San Diego, CA 92161 USA
基金
美国国家卫生研究院;
关键词
Osteoarthritis; Synovium; Cartilage; Innate immunity; Innate inflammatory network; PRR; DAMPs; Crosstalk; Toll-like receptors; GLYCATION END-PRODUCTS; TOLL-LIKE RECEPTORS; TENASCIN-C; CLASSICAL PATHWAY; COMPLEMENT; MATRIX; PATHOGENESIS; HEALTH; FLUID; CHONDROCYTES;
D O I
10.1007/s11926-013-0323-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review focuses on the recent advancements in the understanding of innate immunity in the pathogenesis of osteoarthritis, particularly with attention to the roles of damage-associated molecular patterns (DAMPs), pattern recognition receptors (PPRs), and complement in synovitis development and cartilage degradation. Endogenous molecular products derived from cellular stress and extracellular matrix disruption can function as DAMPs to induce inflammatory responses and pro-catabolic events in vitro and promote synovitis and cartilage degradation in vivo via PRRs. Some of the DAMPs and PRRs display various capacities in driving synovitis and/or cartilage degradation in different models of animal studies. New findings reveal that the inflammatory complement cascade plays a key in the pathogenesis of OA. Crosstalk between joint tissues such as synovium and cartilage communicated at the cellular level within the innate immune inflammatory network is implicated to play an important role in OA progression. Further studies on how the innate immune inflammatory network impacts the OA disease process at different stages of progression will lead to the development of new therapeutic strategies.
引用
收藏
页数:7
相关论文
共 57 条
  • [1] Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice
    Abdollahi-Roodsaz, Shahla
    van de Loo, Fons A. J.
    Koenders, Marije I.
    Helsen, Monique M.
    Walgreen, Birgitte
    van den Bersselaar, Liduine A.
    Arntz, Onno J.
    Takahashi, Nozomi
    Joosten, Leo A. B.
    van den Berg, Wim B.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 1838 - 1847
  • [2] Inflammation in osteoarthritis
    Goldring, Mary B.
    Otero, Miguel
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (05) : 471 - 478
  • [3] RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
    Alexiou, P.
    Chatzopoulou, M.
    Pegklidou, K.
    Demopoulos, V. J.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2010, 17 (21) : 2232 - 2252
  • [4] The role of HMGB1 in the pathogenesis of rheumatic disease
    Andersson, Ulf
    Harris, Helena Erlandsson
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (1-2): : 141 - 148
  • [5] Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors
    Ballanti, Eleonora
    Perricone, Carlo
    di Muzio, Gioia
    Kroegler, Barbara
    Chimenti, Maria Sole
    Graceffa, Dario
    Perricone, Roberto
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (10) : 617 - 623
  • [6] ELUSIVE ROLE FOR TOLL LIKE RECEPTOR 2 IN JOINT PATHOLOGY DURING EXPERIMENTAL OSTEOARTHRITIS
    Blom, A. B.
    van Lent, P. L.
    Abdollahi-Roodsaz, S.
    van der Kraan, P.
    van den Berg, W.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2011, 19 : S18 - S18
  • [7] Toll-like receptors and chondrocytes - The lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of Toll-like receptor 4 and antagonized by bone morphogenetic protein 7
    Bobacz, K.
    Sunk, I. G.
    Hofstaetter, J. G.
    Amoyo, L.
    Toma, C. D.
    Akira, S.
    Weichhart, T.
    Saemann, M.
    Smolen, J. S.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1880 - 1893
  • [8] Bradley K, 1996, IMMUNOLOGY, V88, P648
  • [9] Complement in health and disease
    Carroll, Maria V.
    Sim, Robert B.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (12) : 965 - 975
  • [10] The Pattern Recognition Receptor CD36 Is a Chondrocyte Hypertrophy Marker Associated with Suppression of Catabolic Responses and Promotion of Repair Responses to Inflammatory Stimuli
    Cecil, Denise L.
    Appleton, C. Thomas G.
    Polewski, Monika D.
    Mort, John S.
    Schmidt, Ann Marie
    Bendele, Alison
    Beier, Frank
    Terkeltaub, Robert
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (08) : 5024 - 5031